SMPD2 and chronic obstructive pulmonary disease: Sphingolipids were also increased in the plasma and sputum of COPD patients; the hypothesis was raised that the inhalation of respiratory irritants causes an increase of neutral sphingomyelinase, which in turn converts sphingomyelin into ceramide [53, 54, 55].